Microbial exo-polysaccharides for biomedical applications

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 14, 2010, Pages 1345-1355

  Shih, I L ^a  

^a DA YEH UNIVERSITY   (Taiwan)

Author keywords

Biomedicine; Fermentation; Ionic heteropolysaccharide; Microbial exopolysaccharides; Neutral homopolysaccharide

Indexed keywords

ALGINIC ACID; CELLULOSE; CUPROPHANE; DEXTRAN; EXOPOLYSACCHARIDE; GELLAN; HYALURONIC ACID; IONIC HETEROPOLYSACCHARIDE; LEVAN; NEUTRAL HOMOPOLYSACCHARIDE; POLYSACCHARIDE; PULLULAN; UNCLASSIFIED DRUG; XANTHAN;

ARTICLE; ARTIFICIAL ORGAN; BIOMEDICAL ENGINEERING; BONE REMODELING; DENTISTRY; DRUG DELIVERY SYSTEM; HUMAN; IMPLANTATION; MACROMOLECULE; NONHUMAN; OPHTHALMOLOGY; ORTHOPEDIC SURGERY; OSTEOARTHRITIS; PAIN; PHARMACY; PROSTHESIS; TISSUE ENGINEERING;

ANIMALS; BIOMEDICAL RESEARCH; CELLULOSE; DEXTRANS; GLUCANS; HUMANS; HYALURONIC ACID; POLYSACCHARIDES, BACTERIAL;

EID: 78649828400     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955710793564115     Document Type: Article

References (145)

1. U. S. Congress, Office of Technology Assessment, Biopolymers: Making Materials Nature's Way. OTA-BP-E-102 (Washington, DC: U.S. Govement Printing Office, September), 1993.
2. Sutherland, I. W. Novel and established application of microbial polysaccharides. Trends Biotechnol., 1998, 16, 41-46.
3. Roller, S.; Dea, I. C. M. Biotechnology in the production and modification of biopolymers for foods. Crit. Rev. Biotechnol., 1992, 12, 261-277.
4. Byrom, D. Polymer synthesis by microorganisms: technology and economics. Trends Biotechnol., 1987, 5, 246-250.
5. Sutherland, I. W. Microbial exopolysaccharides-structural subtleties and their consequences. Pure Appl. Chem., 1997, 69, 1911-7.
6. Johns, M. R.; Noor, E. Recovery and purification of polysaccharides form broth. Austral. J. Biotechnol., 1991, 5, 73-77.
7. Dziezak, J. D. A focus on gums. Food Technol., 1991, 45, 116-132.
8. Ciechańska, D. Multifunctional bacterial cellulose/chitosan composite materials for medical applications. Fibers Textiles Eastern Eur., 2004, 12, 69-72.
9. Yalpani, M.; Sanford, P. A. Commercial polysaccharides: recent trends and developments. In: Industrial polysaccharides: genetic engineering, structure, property relations and application; Yalpani, M. Ed.; Elsivier Science: Amsterdam, 1987, pp. 331-335.
10. Prehm, P. Hyaluronan. In: Biopolymers; Vandamme, E. J., De Baets, S., Steinbüchel, A., Eds.; Wiley-VCH: Weinheim, 2002; Vol 5, Polysaccharides I: pp 379-406.
11. Balazs, E. A.; Leshchiner, E.; Larsen, N. E.; Band, P. Application of hyaluronan and its derivatives. In: Biotechnological polymers; Gebelein, C. G., Ed.; Technomic, USA, 1993, pp. 41-65.
12. Sutherland, I. W. Biotechnology of Microbial Exopolysaccharides, Cambridge University Press: Cambridge, 1990.
13. Meyer, K.; Palmer, J. W. The polysaccharide of the vitreous humor. J. Biol. Chem., 1934, 107, 629-634.
14. Weissman, B.; Meyer, K. The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord. J. Am. Chem. Soc., 1954, 76, 1753-1757.
15. O'Regan, M.; Martini, I.; Crescenzi, F.; De Luca, C.; Lansing, M. Molecular mechanisms and genetics of hyaluron biosynthesis. Int. J. Biol. Macromol., 1994, 16, 283-286.
16. Kendall, F. E.; Heidelberger, M.; Dawson, M. H. A serologically inactive polysaccharide elaborated by mucoid strains of group A hemolytic streptococci. J. Biol. Chem., 1937, 118, 61-69.
17. Jesen, C. E. Spreading factors of bacterial origin. Acta Rheum. Scand., 1957, 3, 177-188.
18. Holmstrom, B.; Ricica, J. Production of hyaluronic acid by a Streptoccal strain in batch culture. Appl. Microbiol., 1967, 15, 1409-1413.
19. Johns, M. R.; Goh, L. T.; Oeggerli, A. Effect of pH, agitation and aeration on hyaluronic acid produced by streptococcus zooepidemicus. Biotechnol. Lett., 1994, 16, 507-512.
20. Armstrong, D. C.; Cooney, M. J.; Johns, M. R. Growth and amino acid requirements of hyaluronic-acid-producing Streptococcus zooepidemicus. Appl. Microbiol. Biotechnol., 1997, 47, 309-312.
21. Kim, J. H.; Yoo, S.J.; Oh, D. K.; Kweon, Y. G.; Park, D. W.; Lee, C. H.; Gil, G. H. Selection of a Streptococcus equi mutant and optimization of culture conditions for the production of molecular weight hyaluronic acid. Enzyme Microb. Technol., 1996, 19, 440-445.
22. Stangohl, S. Methods and means for the production of hyaluronic acid. U.S. Patent 6,090,596, 2000.
23. Stangohl, S. Methods and means for the production of hyaluronic acid. U.S. Patent 6,537,795, 2003.
24. Rangaswamy, V.; Dharmendra, J. An efficient process for production and purification of hyaluronic acid from Streptococcus equi subsp. zooepidemicus Biotechnol. Lett., 2008, 30, 493-496.
25. Chong, B. F.; Blank, L. M.; Mclaughlin, R.; Nielsen, L. K. Microbial hyaluronic acid production. Appl. Microbiol. Biotechnol., 2005, 66, 341-51.
26. Yamada, T.; Kawasaki, T. Microbial synthesis of hyaluronan and chitin: New approaches. J. Biosci. Bioeng., 2005, 99, 521-528.
27. Van de Rijn, I.; Kessler, R. E. Growth characteristics of group A streptococci in a new chemically defined medium. Infect. Immun., 1980, 27, 444-448.
28. Goh, L.T. Effect of culture conditions on rates of intrinsic hyaluronic acid production by Streptococcusequi subsp. zooepidemicus. PhD Thesis, University of Queensland, 1998.
29. Praest, B.M.; Helmut, G.; Rudiger, K. Effects of oxygen-derived free radicals on the molecular weight and the polydispersity of hyaluronan solutions. Carbohydr. Res., 1997, 303, 153-157.
30. Mausolf, A.; Jungmann, J.; Robenek, H.; Prehm, P. Shedding of hyaluronate synthase from streptococci. Biochem. J., 1990, 267, 191-196.
31. Leonard, B. A.; Woischnik, M.; Podbielski, A. Production of stabilized virulence factor-negative variants by group A streptococci during stationary phase. Infect Immun., 1998, 66, 3841-3847.
32. Armstrong, D. C.; Johns, M. R. Culture conditions affect the molecular weight properties of hyaluronic acid produced by Streptococcus zooepidemicus. Appl. Environ. Microbiol. 1997, 63, 2759-2764.
33. Balazs, E. A.; Denlinger, J. L. Clinical uses of hyaluronan. In: The Biology of hyaluronan, Ciba Foundation Symposium 143, Wiley, Chichester: England, 1989, pp. 265-280,
34. Burns, J. W.; Colt, M. J.; Burgess, L. S.; Skinner, K. C. Preclinical evaluation of Seprafilm TM bioresorbale membrane. Eur. J. Surg., 1997, 163 (suppl. 577), 40-48.
35. Vercruysse, K. P.; Preswich, G. D. Hyaluronate derivatives in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1998, 15, 513-555.
36. Adams, M. E.; Lussier, A. J.; Peyron, J. G. A Risk-Benefit Assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Saf., 2000, 23, 115-130.
37. Goa, K. L.; Benfield, P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs, 1994, 47, 536-566.
38. Beck, D. E. The role of seprafilm bioresorbable membrane in adhesion prevention. Eur. J. Surg. Suppl., 1997, 163 (suppl. 577), 49-55.
39. Kuo, J.W. Practical Aspects of Hyaluronan Based Medical Products, CRC/Taylor & Francis: Boca Raton, Florida, 2006.
40. Han, Y. W. Microbial levan.Adv. Appl. Microbiol., 1990, 35, 171-194.
41. Rhee, S. K.; Song, K. B.; Kim, C. H.; Park, B. S.; Jang, E. K.; Jan, K. H. Levan. In: Biopolymers; Vandamme, E. J., De Bates, S., Steinbüchel, A., Eds.; Wiley-VCH Verlag GmbH: Weinheim, Germany, 2002, Vol 5, Polysaccharides I: pp.357-377.
42. Dedonder, R. Levansucrase from Bacillus subtilis. Methods Enzymol., 1966, 8, 500-505.
43. Tanaka, T.; Susumu, O.; Yamamoto, T. Synthesis of levan by levansucrase. Some factors affecting the rate of synthesis and degree of polymerization of levan. J. Biochem., 1979, 85, 287-293.
44. Shih, I. L.; Yu, Y. T.; Shieh, C.J.; Hsieh, C.Y. Selective production and characterization of levan by Bacillus subtilis (Natto) Takahashi. J. Agric. Food Chem., 2005, 53, 8211-8215.
45. Shih, I. L.; Yu, Y. T. Simultaneous and selective production of levan and poly-(--glutamic acid) by Bacillus subtilis. Biotechnol. Lett., 2005, 27, 103-6.
46. Hestrin, S.; Avineri-Shapiro, S.; Aschner, A. The enzymatic production of levan. Biochem. J., 1943, 37, 450-456.
47. Melo, I. R.; Pimentel, M. F.; Lopes, C. E.; Calazans, G. M. T. Application of fractional factorial design to levan production by Zymomonas mobilis. Braz. J. Microbiol., 2007, 38, 45-51.
48. Evans, T. H., Hibbert, H. Bacterial polysaccharides. Adv. Carbohydr. Chem., 1946, 2, 253-277.
49. Corrigan, A.; Robyt, J. F. Nature of the fructan of Streptomyces mutant OMZ 176. Infect. Immun., 1979, 26, 386-389.
50. Fuchs, A. Synthesis of levan by Pseudomonads. Nature, 1956, 178,921.
51. Dias, F.; Bhat, J. V. A new levan producing bacterium, Corynebacterium levaniformans nov. spec. Antonie van Leeuwenhoek, J. Microbiol. Serol., 1962, 28, 63-72.
52. Han, Y. W. Levan production by Bacillus polymyxa. J. Ind. Microbiol. 1989, 4, 447-51.
53. Han, Y. W.; Clarke, M. A. Production and characterization of microbial levan. J. Agric. Food Chem., 1990, 38, 393-396.
54. Leibovici, J.; Stark, Y. Increase in cell permeability to a cytotoxic agent by the polysaccharide levan. Cell Mol. Biol., 1985, 31, 337-341.
55. Calazans, G. M. T.; Lima, R. C.; de Franca, F. P.; Lopes, C. E. Molecular weight and antitumor activity of Zymomonas mobilis levans. Int. J. Biol. Marcromol., 2000, 27, 245-247.
56. Schechter, L.; Hestrin, S. Levan as a blood volume expander: relationship of polymer size and behavior in the organism. J. Lab. Clin. Med., 1963, 61, 962-978.
57. Yun, J. W. Fructooligosaccharides-Occurrence, preparation, and application. Enzyme Microb. Technol., 1996, 19, 107-117.
58. Calazans, G. M. T.; Lopes, C. E.; Lima, R. M. O. C.; de Franca, F. P. Antitumor activities of levans produced by Zymomonas mobilis strains. Biotechnol. Lett., 1997, 19, 19-21.
59. Iman, G., M.; Abd-Allah, N. M. Fructosan, a new soil conditioning polysaccharide isolated from the metabolites of Bacillus polymyxa As-1 and its clinical applications. Egypt. J. Bot., 1974, 17, 19-26.
60. Guo, J. H.; Skinner, G. W.; Harcum, W. W.; Barnum, P. E. Pharmaceutical applications of naturally occurring water-soluble polymers. Pharm. Sci. Technol. Today, 1998, 1, 254-261.
61. Vina, I.; Karsakevicha, A.; Toma, M.; Bekers, M. Polysaccharide levan and its derivatives as wide spectrum immunomodulators: biosynthesis, obtaining and investigation.In: 8 th European Congress on Biotechnology (ECB 8); Budapest: Hungary, 1997, pp. 105-106.
62. Vina, I.; Karaskevich, A.; Gonta, S.; Linde, R.; Bekers, M. Influence of some physiochemical factors on the viscosity of aquesous levan solution of Zymomonas mobilis. Acta Biotechnol., 1998, 18, 167-174.
63. Liepa, V.; Zakenfelds, G.; Volpe, E.; Koronova, Y.; Lapsa, R.; Laivenieks, M.; Bekers, M.; Pospishil, I. Levan prolongs the life span of tumor-bearing or irradiated mice and enhances the antitumoral activity of leukocytes. Proc. Latvian. Acad. Sci. B., 1993, 5, 59-64.
64. Yamamoto, Y.; Takahashi, Y.; Kawano, M.; Iizuka, M.; Matsumoto, T.; Saeki, S.; Yamaguchi, H. In vitro digestibility and fermentability of levan and its hypocholesterolemic effects in rats. J. Nutr. Biochem., 1999, 10, 13-18.
65. Clarke, M. A.; Roberts, E. J.; Garegg, P. J. New compounds from microbiological products of sucrose. Carbohydr. Polym., 1997, 34, 425-431.
66. Robert, E.J.; Garegg, P.J. Levan derivatives, their preparation, composition and applications including medical and food application WO98/03184, 1998.
67. Catley, B. J.; Whelan, W. J. Observations on the structure of pullulan. Arch. Biochem. Biophys., 1971, 143, 138-142.
68. Catley, B. J.; Ramsay, A.; Servis, C. Observation on the structure of the fungal extracellular polysaccharide pullulan. Carbohydr. Res., 1986, 153, 79-86.
69. Deshpande, M. S.; Rale, V. B.; Lynch, J. M. Aureobasidium pullulans in applied microbiology: a status report. Enzyme Microb. Technol., 1992, 14, 514-527.
70. Leathers, T. D. Pullulan. In: Biopolymers; Vandamme, E.J., De Baets, S., Steinbüchel, A., Eds.; Wiley-VCH: Weinheim, 2002; Vol 6, Polysaccharides II: pp 1-35.
71. Leathers, T. D. Biotechnological production and applications of pullulan. Appl. Microbiol. Biotechnol., 2003, 62, 468-473.
72. Seviour, R. J.; Stasinopoulos, S. J.; Auer, D. P. F.; Gibbs, P. A. Production of pullulan and other exopolysaccharides by filamentous fungi. Crit. Rev. Biotechnol., 1992, 12, 279-298.
73. Tsujisaka, Y.; Mitsuhashi, M. Pullulan. In: Industrial Gums, Polysaccharides and their Derivatives 3rd ed.; Whistler, R. L., BeMiller, J. N. Eds.; Academic Press, San Diego, 1993, pp. 447-460.
74. Youssef, F.; Roukas, T.; Biliaderis, C.G. Pullulan production by a non-pigmented strain of Aureobasidium pullulans using batch and fed-batch culture. Process Biochem., 1999, 34, 355-366.
75. Slodki, M. E.; Cadmus, S. C. Pullulan. Adv. Appl. Microbiol., 1978, 23, 40-49.
76. Lazaridou, A.; Biliaderis, C. G.; Roukas, T.; Izydorczyk, M. Production and characterization of pullulan from beet molasses using a nonpigmented strain of Aureobasidium pullulans in batch culture Appl. Biocehm. Biotechnol., 2002, 97, 1-22.
77. Fujii, N.; Shinohara, S. Polysaccharide produced by Aureobasidium pullulans FERM-P4257. II. Toxicity test and antitumor effect. Bull. Fac. Agr. Miyazaki Univ., 1986, 33, 243-248.
78. Kimoto, T.; Shibuya, T.; Shiobara, S. Safety studies of a novel starch, pullulan: chronic toxicity in rats and bacterial mutagenicity. Food Chem. Toxicol., 1997, 35, 323-329.
79. Miyamoto, Y.; Goto, H.; Sato, H.; Okano, H.; Iijima, M. Process for sugar-coating solid preparation. U.S. patent 4,610,891, 1986.
80. Izutsu, Y.; Sogo, K.; Okamoto, S.; Tanaka, T. Pullulan and sugar coated pharmaceutical composition. U.S Patent. 4,650,666, 1987.
81. Childers, R. F.; Oren, P. L.; Seidler, W. M. K. Film coating formulations. U.S. Patent 5,015,480, 1991.
82. Leung, S. S.; Leone, R. S.; Kumar, L. D.; Kulkarni, N. Fast dissolving orally consumable films. PCT International Application WO 00/18365, 2000.
83. Hijiya, H.; Shiosaka, M. Adhesives and pastes. U.S. Patent 3,873,333, 1975.
84. Leung, S. S.; Martin, A.; Leone, R. S. Bioadhesive antibacterial wound healing composition. U.S. Patent 6,329,434, 2001.
85. Yamaguchi, R.; Iwai, H.; Otsuka, Y.; Yamamoto, S.; Ueda, K.; Usui, M.; Taniguchi, Y.; Matuhasi, T. Conjugation of Sendai virus with pullulan and immunopotency of the conjugated virus. Microbiol. Immunol., 1985, 29, 163-168.
86. Mitsuhashi, M.; Koyama, S. Process for the production of virus vaccine. U.S. Patent 4,659,569, 1987.
87. Suginoshita, Y.; Tabata, Y.; Matsumura, T.; Toda, Y.; Nabeshima, M.; Moriyasu, F.; Ikada, Y.; Chiba, T. Liver targeting of human interferon-ń with pullulan based on metal coordination. J Control Release., 2002, 83, 75-88.
88. Masci, G.; Bontempo, D.; Crescenzi, V. Synthesis and characterization of thermoresponsive Nisopropylacrylamide/ methacrylated pullulan hydrogels. Polymer., 2002, 43, 5587-5593.
89. Na, K.; Lee, T. B.; Park, K. H.; Shin, E. K.; Lee, Y. B.; Choi, H. K. Self-assembled nanoparticles of hydrophobically modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur. J. Pharm. Sci., 2003, 18, 165-173.
90. Nishikawa, T.; Akioshi, K.; Sunamoto, J. Macromolecular complexation between bovin serum albumin and the selfassembled hydrogel nanoparticles of hydrophobized polysaccharides. J. Am. Chem. Soc., 1996, 118, 6110-6115.
91. Akioshi, K.; Nishikawa, T.; Shichibe, S.; Sunamoto, J. Stabilization of insulin upon supramolecular complexation with hydrophobized polysaccharide nanoparticles, Chem. Lett., 1995, 24, 707-708.
92. Akioshi, K.; Deguchi, S.; Taijima, H.; Nishikawa, T.; Sunamoto, J. Microscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharide. Macromol., 1997, 30, 857-861.
93. Jagur-Grodzinski, J. Biomedical application of functional polymers. React. Funct. Polym., 1999, 39, 99-138.
94. Yoshinaga, F.; Tonouchi, N.; Watanabe, K. Research progress in production of bacterial cellulose by aeration and agitation culture and its application as a new industrial material. Biosci. Biotechnol. Biochem., 1997, 61, 219-224.
95. Watanabe, K.; Tabuchi, M.; Morinaga, Y.; Yoshinaga, F. Structural feature and properties of bacterial cellulose produced in agitated culture. Cellulose, 1998, 5, 187-200.
96. Bielecki, S.; Krystynowicz, A.; Turkiewicz, M.; Kalinowska, H. Bacterial Cellulose. In: Polysaccharides I. In: Biopolymers; Steinbuchel, A., Ed.; Wiley-VCH Verlag GmbH: Munster, Germany, 2002; Vol. 5, pp.37-90.
97. Bielecki, S.; Krystynowicz, A.; Turkiewicz, M.; Kalinowska, H. Bacterial cellulose. In: Biotechnology of Biopolymers; Steinbuchel, A., Doi, Y. Eds.; Willey-VCH: Weinheim, Germany, 2005; Vol.1, pp. 381-434.
98. El-Saied, H.; Basta, A. H.; Gobran, R. H. Research progress in friendly environmental technology for the production of cellulose products (Bacterial Cellulose and Its Application). Polym. Plast. Technol. Eng., 2004, 43, 797-820.
99. Klemm, D.; Heublein, B.; Fink, H.P.; Bohn, A. Cellulose: Fascinating biopolymer and sustainable raw material. Angew. Chem. Int. Ed. Engl., 2005, 44, 3358-3393.
100. Czaja, W.; Krystynowicz, A.; Bielecki, S.; Brown, R. M. Microbial cellulose--the natural power to heal wounds. Biomaterials, 2006, 27, 145-151.
101. Jonas, R.; Farah, L. F. Production and application of microbial cellulose. Polym. Degrad. Stabil., 1998, 59, 101-106.
102. Yang, Y. K.; Park, S. H.; Hwang, J. W.; Pyun, Y. R.; Kim, Y. S. Cellulose production by Acetobacter xylinum RBC5 under agitated condition. J. Ferment. Bioeng.,1998, 85, 312-317.
103. Budhiono, A.; Rosidi, B.; Taher, H.; Iguchi, M. Kinetic aspects of bacterial cellulose formation in nata de coco culture system. Carbohydr. Polym., 1999, 40, 137-143.
104. Kouda, T.; Yano, H.; Yoshinaga, F.; Kaminoyama, M.; Kamiwano, M. Characterization of non- Newtonian behavior during mixing of bacterial cellulose in bioreactor. J. Ferment. Bioeng., 1996, 82, 382-386.
105. Kouda, T.; Yano, H.; Yoshinaga, F. Effect of agitator configuration on bacterial cellulose productivity in aerated and agitated culture. J. Ferment. Bioeng., 1997, 83, 37-61.
106. Sattler, K.; Fiedler, S. Production and application of bacterial cellulose: II. Cultivation in a rotating drum fermentor. Zentralbl. Microbiol., 1990, 145, 247-252 (in German).
107. Bungay, H.R.; Serafica, G. Production of microbial cellulose using a rotating disc film bioreactor. U.S. Patent 5,955,326, 1999.
108. Chao, Y.; Ishida, T.; Sugano, Y.; Shoda, M. Bacterial cellulose production by Acetobacter xylinum in a 50 L internal - loop airlift reactor. Biotechnol. Bioeng., 2000, 68, 345-352.
109. Sakairi, N.; Asano, H.; Ogawa, M.; Nishi, N.; Tokura, S. A method for direct harvest of bacterial cellulose filaments during continuous cultivation of Acetobacter xylinum. Carbohydr. Polym., 1998, 35, 233-237.
110. Tahara, N.; Tabuchi, M.; Watanabe, K.; Yano, H.; Morinaga, Y.; Yoshinaga, F., Degree of polymerization of cellulose from Acetobacter xylinum BPR2001decreased by cellulase produced by the strain. Biosci. Biotechnol. Biochem., 1997, 61, 1862-1865.
111. Toyosaki, H.; Naritomi, T.; Seto, A.; Matsuoka, M.; Tsuchida, T.; Yoshinaga, F. Screening of bacterial cellulose-producing Acetobacter strains suitable for agitated culture. Biosci. Biotechnol. Biochem., 1995, 59, 1498-1502.
112. Chao, Y.; Sugano, Y.; Shoda, M. Bacterial cellulose production under oxygen-enriched air at different fructose concentrations in a 50-liter internal-loop airlift reactor. Appl. Microbiol. Biotechnol., 2001, 55, 673-679.
113. Krystynowicz, A.; Czaja, W.; Wiktorowska-Jezierska, A.; Goncalves-Mikiewicz, M.; Turkiewicz, M.; Bielecki, S. Factors affecting the yield and properties of bacterial cellulose. J. Ind. Microbiol. Biotechnol., 2002, 29, 189-195.
114. Oikawa, T.; Morino, T.; Ameyanea, M. Production of cellulose from D-arabitol by Acetobacter xylinum KU-1. Biosci. Biotechnol. Biochem., 1995, 59, 1564-1565.
115. Naritomi, T.; Kouda, T.; Yano, H.; Yoshinaga, F. Effect of lactate on bacterial cellulose production from fructose in continuous culture. J. Ferment. Bioeng., 1998, 85, 89-95.
116. Schmitt, D. F.; Frankos, V. H.; Westland, J.; Zoetis, T. Toxicologic evaluation of cellulose fiber: genotoxicity, pyrogenicity, acute and sub-chronic toxicity. J. Am. Coll. Toxicol., 1991, 10, 541-554.
117. Chung, Y.; Shyu, Y. The effects of pH, salt, heating, and freezing on the physical properties of bacterial cellulose-nata. Int. J. Food Sci.Tech., 1999, 34, 23-26.
118. Fontana, J. D.; Desouza, A. M.; Fontana, C. K.; Torriani, I. L.; Moreschi, J. C.; Gallotti, B. J.; Desouza, S. J.; Narcisco, G. P.; Bichara, J. A.; Farah, L. F. X. Acetobacter cellulose pellicle as a temporary skin substitute Appl. Biochem. Biotechnol., 1990, 24, 253-264.
119. Novaes, A. B. Soft tissue management for primary closure in guided bone regeneration: Surgical technique and case report. Int. J. Oral Maxillofac. Implants., 1997, 12, 84-87.
120. Klemm, D.; Schumann, D.; Udhart, U.; Marsch, S. Bacterial synthesized cellulose - artificial blood vessels for microsurgery. Prog. Polym. Sci., 2001, 26, 1561-603.
121. Ammon, H. P. T.; Ege, W.; Oppermann, M.; Gõpel, W.; Eiselet, S. Improvement in the long term stability of an amperometric glucose sensor system by introducing a cellulose membrane of bacterial origin. Anal. Chem.,1995, 67, 466-471.
122. Neely, W. B. Dextran: structure and synthesis. In: Advance In Carbohydrate Chemistry; Wolfrp, M. L., Tipson, R. S., Eds.; Academic Press, New York, 1960; 15, 341-369.
123. Bijerinck, M.W. K. Mucilaginous substances of the cell wall produced from can sugar form Leuconostoc mesenteroides NRRLB-512F, 1912, GenBank Accession No. U81374.
124. Hehre, E. J. Production from sucrose of a serologically reactive polysaccharide by a sterile bacterial extract. Science, 1941, 93, 237-238.
125. Leathers, T. D. Dextran. In: Biopolymers; Vandamme, E. J., De Baets, S., Steinbuchel, A., Eds.;Wiley-VCH: Weinheim, 2002; Vol. 5, pp. 299-321.
126. Vandamme, E. J.; Bruggeman, G.; De Baets, S.; Vanhooren, P. T. Useful polymers of microbial origin. Agro-Food Ind. Hi-Tech., 1996, 7, 21-25.
127. De Belder, A.N. Dextran. In: Industrial Gums. Polysaccharides and their derivatives, 3rd ed.; Whistler, R. L., BeMiller, J. N., Eds., Academic Press: San Diego, CA, 1993, pp. 399-425.
128. Qader, S. A. U.; Iqbal, L.; Aman, F.; Shireen, E.; Azhar, A. Production of dextran by newly isolated strains of Leuconostoc mesenteroides PCSIR-3 and PCSIR-9. J. Turk. J. Biochem., 2005, 31, 21-26.
129. Alcalde, M.; Plou, F. J.; Gómez de Segura, A.; Remaud-Simeon, M.; Willemot, R. M.; Monsan, P.; Ballesteros,A. Immobilization of native and dextran-free dextransucrases from Leuconostoc mesenteroides NRRL B-512F for the synthesis of glucooligosaccharides. Biotechnol. Tech., 1999, 13, 749-755.
130. Sutherland, I. W. Extracellular polysaccharides. In: Biotechnology; Rehm, H.J., Reed, G., Eds.; Wiley-VCH: Weinheim, 1996, Vol. 6, pp. 615-657.
131. Sutherland, I.W. Polysaccharases for microbial polysaccharides. Carbohydr. Polym., 1999, 38, 319-328.
132. De Belder, A. N. Medical application of dextran and its derivatives. In: Polysaccharides in Medicinal Applications; Dumitriu, S., Ed.; Marcel Dekker: New York, 1996, pp.505-523.
133. Piret, J.; Lamontagne, J.; Bestman-Smith, J.; Roy, S.; Gourde, P.; Désormeaux, A.; Omar, R.F.; Juhász, J.; Bergeron, M.G. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses. J. Clin. Microbiol., 2000, 38, 110-119.
134. Banik, R.M.; Kanari, B.; Upadhyay, S. N. Exopolysaccharide of the gellan family: prospects and potential. World J. Microbiol. Biotechnol., 2000, 16, 407-414.
135. Rehm, B.H.A. Alginates from bacteria. In: Biopolymers; Vandamme, E. J., De Baets, S., Steinbuchel, A., Eds.; Wiley-VCH: Weinheim, 2002, Vol. 5, pp. 179-212.
136. Born, K.; Langendorff, V.; Boulenguer, P. Xanthan. In: Biopolymers; Vandamme, E. J., De Baets, S., Steinbuchel, A. Eds.; Willey- VCH, Weinheim, Germany, 2002, Vol. 5, pp. 259-297.
137. Meseguer, G.; Buri, P.; Plazonnet, B.; Rozier, A.; Gurny, R. Gamma scintigraphic comparision of eye drops containing pilocarpine in healthy volunteers. J. Ocular Pharmacol. Ther., 1996, 12, 481-488.
138. Carlfors, J.; Edsman, K.; Peterson, R.; Jornving, K. Rheological evaluation of gelrite in situ for opthalmic use. Eur. J. Pharm. Sci., 1998, 6, 113-119.
139. Manna, B.; Gambhir, A.; Ghosh, P. Production and rheological characterstics of the microbial polysaccharide gellan. Lett. Appl. Microbiol., 1996, 47, 141-145.
140. Alhaique, F.; Santucci, E.; Carafa, M.; Coviello, M.; Murtas, E.; Riccieri, F. M. Gellan in sustained release formulations: preparation of gel capsules and release studies. Biomaterials, 1996, 17, 1981-1986.
141. Gutowska, A.; Jeong, B.; Jasionowski, M. Injectable gels for tissue engineering. Anatom. Rec., 2001, 263, 342-349.
142. Espevik, T., Skjåk-Bræk, G. Application of alginate gels in biotechnology and biomedicine. Carbohydr. Eur., 1996, 14, 19-25.
143. Jana, A. K.; Ghosh, P. Stimulation of xanthan production by Xanthomonas compestris. World J. Microbiol. Biotechnol., 1997, 13, 261-264.
144. Sanchez, A.; Rami'rez, M. E.; Torres, L. G.; Galindo, E.; Mob, W. J. Characterisation of xathan from selected Xanthomonas strains cultivated under constant dissolved oxygen. World J. Microbiol. Biotechnol., 1997, 13, 443-451.
145. Philipon, P. Des médicaments libérés sur commande: Génie médical: les atouts des biopolymères. Biofutur (Puteaux). Lavoisier, 1997, 171, 25-27.